MARKET

GNPX

GNPX

Genprex Inc
NASDAQ
2.320
-0.110
-4.53%
Closed 18:22 12/17 EST
OPEN
2.400
PREV CLOSE
2.430
HIGH
2.450
LOW
2.300
VOLUME
83.63K
TURNOVER
85.35K
52 WEEK HIGH
63.00
52 WEEK LOW
2.300
MARKET CAP
5.38M
P/E (TTM)
-0.0439
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GNPX last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at GNPX last week (1201-1205)?
Weekly Report · 12/08 10:17
Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of
Benzinga · 12/04 23:50
Weekly Report: what happened at GNPX last week (1124-1128)?
Weekly Report · 12/01 10:13
Genprex Faces Nasdaq Delisting Risk Over Compliance Shortfalls
Reuters · 11/26 13:01
Genprex Reports Early Success For Its New Gene Therapy In Advanced Lung Cancer Trial
Benzinga · 11/24 12:17
Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy
TipRanks · 11/24 12:10
DATA FROM GENPREX'S ACCLAIM-1 PHASE 1 GENE THERAPY CLINICAL TRIAL PUBLISHED IN CLINICAL LUNG CANCER
Reuters · 11/24 12:00
More
About GNPX
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Company's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which uses lipid-based nanoparticles in a lipoplex form to deliver tumor suppressor gene-expressing plasmids to cancer cells. Its oncology drug candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is developed in combination with approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). GPX-002 is being developed by the Company using the same construct for the treatment of both Type 1 diabetes and Type 2 diabetes. GPX-002 for Type 1 diabetes is designed to work by transforming alpha cells in the pancreas into functional beta-like cells.

Webull offers Genprex Inc stock information, including NASDAQ: GNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNPX stock methods without spending real money on the virtual paper trading platform.